Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Get It Right the First Time: Selection of Antimicrobial Therapy for C. difficile

Access Activity

Overview / Abstract:

This CME Touchpoint digital newsletter is a great way to bring clinicians up to date on the guideline recommendations for the selection of antimicrobial therapy when treating initial and recurrent C. difficile infection. Dr. Feuerstadt and Dr. Khanna review the latest clinical trial data and treatment guidelines for C. difficile infection. The digital newsletter includes text-based content, faculty video commentary, graphics, and supplemental resources.

The Centers for Disease Control and Prevention continues to classify C. difficile as an urgent threat given the great burden on patients and the healthcare system. This Gram-positive bacterium causes diarrhea, abdominal bloating, and colitis in addition to significant morbidity and mortality, increased healthcare costs, and hospital readmission rates. In response to accumulating clinical trial evidence and real-world data, guideline recommendations on the selection of antimicrobial therapy have changed. Clinicians may not be familiar with these changes in the selection and application of antimicrobial therapies for treating initial and recurrent CDI.

Expiration

Apr 14, 2023

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Online

Credits / Hours

1.0 AMA PRA Category 1 Credit

Accreditation

ACCME

Presenters / Authors / Faculty

Paul Feuerstadt, MD, FACG, AGAF
Gastroenterology Center of Connecticut
Assistant Clinical Professor of Medicine
Yale University School of Medicine
Hamden, CT

Sahil Khanna, MBBS, MS, FACG
Professor of Medicine
Gastroenterology and Hepatology
Mayo Clinic
Rochester, MN

Sponsors / Supporters / Grant Providers

Supported by an educational grant from Merck & Co., Inc.

Keywords / Search Terms

ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Newsletter, C. difficile, CME, ACG, Dr. Feuerstadt, Dr. Khanna, gut microbiome, recurrent, infections, infectious disease, gastroenterology, physician, pharmacists, live symposium, microbiota restoration therapy, fidaxomicin, IDSA/SHEA, bezlotoxumab, vancomycin Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map